01.03.2013 Views

EC DG RTD Mr Quintana Trias 7.2.2012

EC DG RTD Mr Quintana Trias 7.2.2012

EC DG RTD Mr Quintana Trias 7.2.2012

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

Communication on “Partnering<br />

in Research and Innovation”<br />

COM(2011) 572 final<br />

Dr. Octavi <strong>Quintana</strong> <strong>Trias</strong>, Director<br />

European Commission, <strong>DG</strong> Research & Innovation<br />

EESC: Public Hearing on Partnering on Research and<br />

Innovation (7 February 2012)


What is Partnering?<br />

Brings together Public players in P2Ps as well as public<br />

and Private players in PPPs to:<br />

• Build critical mass to ensure scale and scope;<br />

• Facilitate joint vision development and strategic agenda<br />

setting;<br />

• Pursue a programming approach;<br />

• Provide for flexible structures and arrangements.


Why we need Partnering?<br />

• Scarce public and private resources to fund research and<br />

innovation in Europe<br />

• Low level of coordination<br />

• Fragmentation and duplication<br />

• Need to address major challenges<br />

• Need to strengthen Europe's competitive<br />

position<br />

• New relationship with stakeholders as partners<br />

Example: Rare Diseases


ERA-NET on Rare Diseases:<br />

E-Rare<br />

• At least 6-8000 known rare diseases, affecting some<br />

29 million EU citizen<br />

• E-Rare from 2006 on: common European<br />

programme of 12 EU countries on rare disease<br />

research, 3 joint calls of € 10 million<br />

• Up to 40% of public research in this area now<br />

coordinated together with FP7 rare diseases related<br />

calls


Objectives of the Partnering Communication<br />

• Draw Lessons with regard to Public-Public Partnerships<br />

(P2Ps) and Public-Private Partnerships (PPPs)<br />

• Identify Steps to Improve Implementation of<br />

Partnering<br />

• Draw the initial lessons from the Active and Healthy<br />

Ageing pilot European Innovation Initiative and their<br />

implications for future EIPs<br />

• Fulfil Legislative Requests from Council


Levels of P2P<br />

Policy level<br />

Joint Programming addressing Societal Challenges<br />

SET Plan (European Energy Research Alliance)<br />

Programme level<br />

ERA-NET<br />

ERA-NET Plus<br />

Article 185 initiatives<br />

Europe INNOVA/PRO INNO Europe


Examples for P2Ps<br />

Joint Programming Initiative on<br />

Neurodegenerative Diseases: JPND<br />

• Recognised by MS as a major societal<br />

challenge- 23 EU countries involved<br />

• Pilot call (a total budget of<br />

€ 14 million)<br />

Article 185 Initiative on metrology<br />

(EMRP)<br />

• 44% of overall metrology resources in one<br />

initiative<br />

• Multiannual joint programme (over €400<br />

million)


Levels of PPPs<br />

Institutionalised PPPs<br />

Joint Technology Initiatives<br />

SESAR<br />

Contractual PPPs / Voluntary Agreements<br />

Recovery PPPs<br />

Future Internet<br />

COLIPA<br />

European Industrial Initiatives of the SET Plan


Examples for PPPs<br />

Clean Sky Joint Technology Initiative<br />

• New, environmentally-friendly aeroplanes<br />

• After 2,5 years of operation, the first flight tests<br />

carried out (€232 million)<br />

Factories of the Future PPP under the<br />

European Recovery Plan<br />

• New and sustainable manufacturing<br />

technologies (€ 1.2 billion)<br />

• A broad range of industrial stakeholders


Lessons learnt<br />

Ensure involvement of partners on long-term basis:<br />

MS: multi-annual financial commitments<br />

Need for public declaration by MS and industry leaders<br />

Article 185 Initiatives: Firm Commitments to Financial<br />

Integration<br />

Single, more Flexible ERA-NET Instrument<br />

Need for “ERA Framework” to Focus on Overcoming<br />

Obstacles (cross-border funding, knowledge circulation,<br />

open access)


Who benefits and how?<br />

• Citizens – through quicker access to products and<br />

services with the potential to significantly impact our lives<br />

• Scientists – through the opportunity to work with peers<br />

across Europe<br />

• Businesses – able to sell new products and services

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!